Global Asthma Devices and COPD Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) – Global Opportunity Analysis and Industry Forecasts, 2015 – 2022 : Acute Market Reports

COPD and asthma devices, namely inhalers and nebulizers, are the most dynamic solution for the treatment of patients suffering from chronic obstructive pulmonary disease and asthma. The world COPD and asthma devices market is categorized, based on the types of devices, into inhalers and nebulizers. These two devices are frequently used in the treatment of COPD and asthma. Inhalers are small handheld devices that are used to deliver medicines for the treatment of chronic obstructive pulmonary disease (COPD). Presently, there are three types of inhalers available in the market such as dry powder inhalers, metered dose inhalers, and soft mist inhalers. In addition, inhalers are available in two forms, i.e. rescue inhalers and maintenance inhalers. Inhalation route is the fastest and most effective method of delivering medications to the respiratory system during treatment of COPD and asthma. This type of treatment is known as combination therapy, in which a combination of two control medications is delivered through an inhaler.

Browse Full Report Visit – http://www.acutemarketreports.com/report/copd-asthma-devices-market

The World COPD and asthma devices market is likely to grow steadily because factors such as steady increase in incidence of pulmonary disorders and improper lifestyle (smoking habits) are expected to have a sustained effect on the market during the extended forecast period. The market is likely to grow steadily in the emerging economies owing to the high cost barriers for refilling these devices.

Market Segmentation Review:

The World COPD and asthma devices market comprises two key segments namely, product type and geography. The product type market considered in this report includes Inhalers which comprises of Drug Powder Inhalers, Metered Dose Inhalers & Soft Mist Inhalers. Based on geography, the World COPD and Asthma Devices is categorized into North America, Europe, Asia Pacific & LAMEA. North America was the leading region in the market in 2015, and expected to continue leading market thoughout analysis period.

Key factors impacting the market:

The key players in the market face price competition from the local device manufacturers. In the developing and underdeveloped regions, the local manufacturers sell these COPD and asthma devices at lower prices owing to the availability of cheap raw materials, thus restraining growth of the market (in terms of value). COPD and asthma treatment is a long and expensive process; affordability of the treatment cost is a core-restraining factor for seeking treatment (services and products/devices). Reimbursements are unavailable or inadequate in many of the developing and underdeveloped nations. Rising percentage of smokers is expected to significantly affect the adoption of these devices by 2020. Portable devices are the only alternative for nebulizer treatments in COPD and asthma. The usage of the portable devices is likely to grow in the near future owing to the inherent benefits of these devices. By 2020, the impact of pollution is likely to worsen worldly, owing to the industrialization of areas and rising number of vehicles. Currently, government initiatives and rising healthcare expenditure have a notable impact on the COPD and asthma devices market, which would enhance over the analysis period. SMIs deliver metered dosage of medication as a soft mist. Rising adoption of these devices is likely to drive the growth of COPD and asthma devices market by 2020. Also, the Patent expiration of popular drugs is a key opportunity for the market due to the increasing availability of generic drugs that can be incorporated in COPD and asthma devices.

Browse All Reports of This Category – http://www.acutemarketreports.com/category/medical-equipments-market

Top winning strategies:

Product launch, agreement and collaboration are the top three winning strategies adopted by key players in the World COPD and Asthma Devices Market. Key players profiled in this report are, Novartis AG, GlaxoSmithKline, Boehringer Ingelheim GmbH, and AstraZeneca Plc. Most of these companies belong to the North American and European regions with strong distribution network globally. The major players in the COPD asthma devices market are focusing majorly on the product innovation and approvals strategy. The prominent players in the market are also undergoing collaborations and expansion which will further propel the growth of the COPD asthma devices market.

Government regulations in Europe and the U.S.:

Governments across each country have implemented regulations for the production, standardization, and utilization of COPD devices. These devices are divided into categories such as Class-I, Class-II, Class-III, and Class-IV, depending upon the level of risk associated with it. In Europe, the European commission is the regulatory authority that regulates the Medical Device Directories (MDD), which harmonize medical devices in European Union. In the U.S., it is mandatory for the manufacturers and initial distributors of medical devices to register their establishments with FDA and list their products. Communaute Europeenne (CE) marking certification is mandatory for all the medical devices sold in Europe. This certification requires only proof of safety, whereas the U.S. FDA requires evidence of both safety and efficacy of a device.

KEY BENEFITS

This report offers the following benefits in particular:

• The market estimations in this report are based on high-end analysis of the key segments from 2015 to 2022.
• Extensive analysis of the world COPD and asthma devices market, by product, helps in understanding the various types of devices used for the treatment of respiratory conditions.
• This report provides comprehensive analysis of factors that drive and restrict growth of the COPD and asthma devices market.
• Porter’s Five Forces model provides an in-depth analysis of the bargaining power of buyers and suppliers, threats of new entrants and substitutes, and competition among the key market players.
• Competitive intelligence highlights the business practices adopted by leading market players across various geographies.
• SWOT analyses of market players enable the study of the internal environment and strategies adopted by them.

COPD AND ASTHMA DEVICES MARKET SEGMENTATION

BY PRODUCT TYPE

Inhalers
Drug Powder Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Soft Mist Inhalers (SMIs)
Nebulizers
Compressor Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
BY GEOGRAPHY

North America
USA
Canada
Mexico
Europe
UK
France
Germany
Asia Pacific
India
China
Japan
Australia
Others
LAMEA
Latin America
Middle East
Africa
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Primary research
1.4.2 Secondary Research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2027
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Website : http://www.acutemarketreports.com

————————
Contact Details:
————————
Rahul Duwedi | Acute Market Reports
Email Id: pramod@acutemarketreports.com
http://www.acutemarketreports.com/